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Background – Many studies focusing on clinical and histological signs of canine atopic dermatitis (AD) have
been published since its early descriptions decades ago. Findings of these studies contributed to our current
knowledge about the disease pathogenesis and allowed establishment of diagnostic criteria used by clinicians
and researchers.
Objectives – This review serves as an update on the clinical and histological features of canine AD published by
the American College of Veterinary Dermatology Task Force on Canine Atopic Dermatitis in 2001 and summa-
rizes the recent discoveries in these fields.
Results – The overall findings of studies focusing on clinical features mirrored those published by the Task Force
in 2001. The novelty was the larger number of animals included in these studies, which allowed establishment of
a new set of diagnostic criteria that exceeded the sensitivity and specificity of the previous criteria. The same
study uncovered some clinical differences between dogs with food-induced and nonfood-induced AD; however,
the authors concluded that these two entities cannot be distinguished based on clinical signs only. Another study
demonstrated some major breed-specific phenotypes. Several publications addressed the histological features
of canine AD skin lesions in experimental models of AD, but none of those addressed naturally occurring lesions.
Nevertheless, the histopathological description of the skin reactions was generally similar to that published by
the Task Force in 2001.
Conclusions – Considerable work has been done in recent years to provide a better definition of the clinical
appearance and histopathology of canine AD. New sets of diagnostic criteria have been developed, and additional
breed-associated differences in phenotypes have been demonstrated.
Introduction
Canine atopic dermatitis (AD) has been the object of
investigation for many decades. Discoveries in the clini-
cal, histological, immunological and epidemiological
aspects of the disease led to the definition of canine AD
as a genetically predisposed inflammatory and pruritic
allergic skin disease with characteristic clinical features
associated with immunoglobulin E (IgE) antibodies, most
commonly directed against environmental allergens.1
Despite the many years of research, investigations of clin-
ical and histological features of AD in dogs are still of
interest to many clinicians and researchers because they
allow us not only to diagnose the disease more precisely,
but also to obtain an insight into the possible pathomech-
anism of the condition.
Clinical manifestations of canine atopic
dermatitis
Historical perspective
Since the early descriptions of canine AD more than
seven decades ago, several studies focusing on clinical
signs and, later, their reliability as diagnostic criteria have
been published and reviewed.2 Pruritus, especially of the
feet, face and axillae, was described in some of the early
publications focusing on the cutaneous manifestations of
canine AD.3,4 The following 10 years brought studies
orientated more specifically on the types of skin lesions
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and their quantification.5–7 As a result, clinical criteria for
canine AD were proposed by Willemse (1986) and were
later amended by Prelaud et al. (1998)8,9 The latter criteria
included a steroid-responsive pruritus, erythema of the
pinnae, bilateral cranial erythematous pododermatitis,
cheilitis and appearance of first signs between the ages
of 6 months and 3 years. Prelaud’s criteria were validated
but were based on a small population of dogs with a lim-
ited geographical distribution.
In 1999, the American College of Veterinary Dermatol-
ogy (ACVD) Task Force on Canine AD undertook a review
of the available literature on canine AD. As a result, a
series of manuscripts, including one on the clinical pheno-
type of canine AD, were published in 2001. This
manuscript established the picture of ‘typical’ clinical
manifestations of canine AD.2 This valuable information,
together with the identification of diagnostic criteria by
Willemse and Prelaud, have been important steps in cre-
ating the first validated scoring system for use in clinical
trials, called the Canine Atopic Dermatitis Extent and
Severity Index (CADESI-03).10 Although rigorously vali-
dated, CADESI-03 has shown limited use by veterinarians
because of its time-consuming nature. Indeed, multiple
clinical trials have published so-called ‘modified CADESI-
03’ to allow for more convenient assessment of the
enrolled cases. Such scoring systems are, however, not
validated, which needs to be taken into account when
interpreting the study results or conducting systematic
reviews.
A handful of studies focusing on clinical manifestations
of canine AD have been published since 2001.11–17 These
studies have included a total of 2880 dogs from North
and South America, Europe, Japan and Australia and
enhanced our current knowledge about the clinical pheno-
type of canine AD. In addition, a new set of diagnostic cri-
teria was proposed in 2010 (Table 1, criteria set 1).12 In
contrast to the previously proposed criteria, selection of
these criteria and their validation were based on data
analysis from a large number of dogs (1096 dogs) and
included 15 different countries worldwide. This set of cri-
teria has been shown to have 85% sensitivity and 79%
specificity for the diagnosis of AD in dogs exhibiting five
of the criteria, which exceeds the sensitivity and specific-
ity of previously proposed criteria by Willemse and
Prelaud et al.8,9,12 The growing knowledge about the clin-
ical phenotypes of canine AD and the need for a more
convenient validated scoring system led subsequently to
the development of two additional validated scoring sys-
tems, Canine Atopic Dermatitis Lesion Index (CADLI) and
CADESI-04.18,19
Update on clinical manifestations of canine atopic
dermatitis
Review of the literature focusing on clinical aspects of
canine AD published after 2001 strongly supports previ-
ously published data in most instances.2 Although his-
torically, cutaneous adverse food reaction and canine
AD have been considered as separate entities, the
majority of the recent publications focusing on clinical
description of canine AD included dogs with so-called
food-induced AD in their data analysis and clearly dem-
onstrated only negligible clinical differences between
the AD associated with environmental allergens and
that of the food-induced AD.12,14–17 Overall, these stud-
ies included a total of 2880 dogs with either AD associ-
ated with environmental allergens or food-induced AD
from all around the world and provided additional infor-
mation on canine AD.11–17
Age of onset
Review of the literature confirmed that the majority of
dogs developed signs of atopic dermatitis before the age
of 3 years, with the mean age of onset being 1.7, 2.2 and
2.7 years, depending on the publication.11–17 A publica-
tion focusing on breed-related differences reported that
French bulldogs and shar-pei dogs appeared to develop
AD earlier in their life than other breeds.16
Another study using the same population of dogs
assessed the differences in the age of onset between
canine AD associated with environmental allergens and
food-induced AD.12 This demonstrated that dogs with
food-induced AD were more likely to be very young
(<1 year, 46.5 versus 38.6%) or older (>6 years, 8.7 ver-
sus 3.8%) in comparison to dogs with AD associated with
environmental allergens.12
Breed predisposition and breed-specific phenotypes
Although there were some minor geographical differ-
ences in the breed predisposition, most studies agreed
that West Highland white terrier (WHWT), Labrador
retriever, golden retriever, boxer, French bulldog, Ger-
man shepherd and cocker spaniel dogs represented the
most commonly affected breeds.11–17 It is suspected
that the regional popularity of some particular breeds or
the different genetic background in different geographi-
cal areas affected the proportions of some breeds
in these reports. For example, the Vizsla was one of
the most commonly affected breeds in a study from
Hungary, while the Cavalier King Charles spaniel, great
dane and silky terrier were breeds found to be predis-
posed to canine AD based on a population study from
Australia.13,15
Table 1. Favrot’s two proposed criteria sets for the diagnosis of
canine atopic dermatitis12
Criteria set 1:
Age at onset under 3 years of age
Dog living mostly indoors
Glucocorticoid-responsive pruritus
Chronic or recurrent yeast infections
Affected front feet
Affected ear pinnae
Nonaffected ear margins
Nonaffected dorsolumbar area
Sensitivity for five criteria, 85.4%; specificity for five criteria, 79.1%
Sensitivity for six criteria, 58.2%; specificity for six criteria, 88.5%
Criteria set 2:
Age at onset under 3 years of age
Dog living mostly indoors
Pruritus without lesions at onset
Affected front feet
Affected ear pinnae
Nonaffected ear margins
Nonaffected dorsolumbar area
Sensitivity for five criteria, 77.2%; specificity for five criteria, 83.0%
Sensitivity for six criteria, 42.0%; specificity for six criteria, 93.7%
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Sex predilection
In contrast to the inconclusive results on sex predilection
in the 2001 review, all reviewed studies published after
2001 agreed that canine AD, in general, does not exhibit
sex predilection.2,11–17 Breed-related exceptions, how-
ever, were noted in one study, which reported that
female boxers and male golden retrievers suffered with
canine AD more frequently.16
Seasonality
While food-induced AD presents with strictly nonseason-
al signs, seasonality can be appreciated in some dogs
with AD associated with environmental allergens. More-
over, it remains a well-accepted fact that, in some dogs,
seasonality can be appreciated initially, but it might be
lost eventually with the disease progression.2
All but one publication focusing on clinical aspects of
canine AD published after 2001 included data on the
seasonal character of the disease.11,12,14–17 The percent-
age of dogs exhibiting seasonal signs varied from 15 to
62%, with the median being 30%. The high variability in
seasonality could be explained by the geographical differ-
ences or possibly by the fact that some studies included
only chronic cases, in which the seasonality of the dis-
ease was recorded at the time of presentation but not at
disease onset.
According to studies in which information about the
specific seasonal distribution could be found, the majority
of seasonally affected dogs exhibited clinical signs in the
spring and/or summer.11,14,17
Clinical features of canine atopic dermatitis
The most common feature of canine AD is pruritus,
which in the majority of analysed dogs appears to pre-
cede other clinical signs (this has been termed pruritus
sine materia in some publications) and is steroid
responsive.11,12,16 The most commonly involved body
regions included distal limbs (62–81% of dogs), face
(27–57% of dogs), ventrum (39–66% of dogs) and ears
(48–60% of dogs).11–17 The involvement of flexural
areas was reported in 38% of dogs with AD.12,16 Some
breeds appeared to exhibit more specific phenotypes,
including shar-pei and WHWT dogs with more frequent
pruritus and lesions on the dorsolumbar area or German
shepherd dogs with lesions affecting elbows, hindlimbs
and thorax.16
It is well accepted that, in addition to pruritus, dogs
with AD can present with a variety of primary or sec-
ondary skin lesions. Some of the most common
lesions seen in canine AD are erythema, erythematous
macular or papular eruptions, self-induced alopecia,
excoriations, hyperpigmentation and lichenification.2
Additionally, yeast and bacterial infections have been
reported as frequent complications affecting dogs with
AD.2 This statement was confirmed by recent studies,
in which a concurrent yeast or bacterial infection was
reported in 28–33 or 55–66% of dogs, respec-
tively.12,14–17 Some less common clinical features,
such as urticaria (2–3%), hot spots (1–11%), hyperhi-
drosis (4–13%), interdigital fistulae (13–22%) and
seborrhoea oleosa (8–14%), were assessed in the
recent publications.12,14–16 Significant dog breed differ-
ences were noted for some of these lesions; for
example, urticaria was more often seen in boxers,
interdigital fistulae were more common in Labrador
retrievers, pyotraumatic dermatitis was detected more
often in German shepherds, golden and Labrador
retrievers, and seborrhoea oleosa with hyperhidrosis
were more frequent in West Highland white terriers
and German shepherds (Table 2).16 Interestingly, no
major differences in clinical phenotype were noted
between AD associated with environmental allergens
and food-induced AD.14
Noncutaneous conditions associated with canine AD. Ca-
nine AD can present with concurrent nondermatological
signs, such as rhinitis or conjunctivitis. Some of the
recent publications focusing on the clinical phenotype of
canine AD included assessment of such presentations in
their data. Concurrent signs of conjunctivitis were
reported in 21–30% of dogs with AD, while rhinitis was
recorded in ~7% of included dogs.12,14–16 This prevalence
of atopic conjunctivitis was lower than previously
reported, and it was also lower than that reported in an
ophthalmology study.5,6,20 The latter investigators
detected ~60% prevalence of an allergic conjunctivitis in
dogs with AD.20 The variations in the prevalence of con-
junctivitis could be due to differences in the population or
environment or to study design, particularly when the
assessment of the prevalence of the ocular disease rep-
resents the priority of the study.
Additionally, one study showed that bacterial coloniza-
tion of the conjunctival sac of dogs with AD was more
frequent than in healthy dogs and that the most
frequently cultured bacteria was Staphylococcus pseud-
intermedius.21 In addition, atopic dogs had significantly
higher numbers of keratinized epithelial cells and lym-
phocytes on cytology from the conjunctival sac, and
eosinophils were seen only in the cytology from dogs
with AD.
Table 2. Examples of breed-specific clinical phenotypes in canine
atopic dermatitis16
Breed-specific distribution
of clinical signs Breed-specific clinical lesions
Dalmatians – lips Boxers – increased urticaria
and otitis
French bulldogs – axillae,
eyelids and flexor surfaces
Dalmatian – decreased frequency
of pruritus without lesions
German shepherd dogs –
elbows, hindlimbs, thorax
and generalized
German shepherd dogs – increased
seborrhoea and hot spots,
decreased pruritus without lesions
Shar-peis – thorax, hindlimbs,
flexor surfaces and
dorsolumbar skin
Golden retrievers – increased
hot spots
West Highland white terriers –
dorsolumbar skin, feet, flexor
surfaces, lips, face, genitals
and generalized
Labradors – increased dry skin
and hot spots, increased
incidence of interdigital fistulae
Shar-peis – increased otitis and
decreased pruritus without lesions
West Highland white terriers –
increased seborrhoea,
Malassezia dermatitis, decreased
frequency of conjunctivitis
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Clinical appearance and histology of AD
Histopathological manifestations of canine
atopic dermatitis
Historical perspective
Histopathological features of canine AD have been under-
reported over the years. The first detailed description of
histological features of canine AD established epidermal
hyperplasia, orthokeratotic and parakeratotic hyperkerato-
sis, hypergranulosis, spongiosis, melanosis and leucocyte
exocytosis as the most common histological findings.5 In
this study, mast cells appeared to be increased in number
and eosinophils were detected in only 15% of evaluated
cases. Additional studies involving histological and immu-
nohistochemical stains further characterized the cell types
of the inflammatory infiltrate in canine AD.22 Briefly, the
perivascular infiltrate seen in canine AD was mixed, com-
posed of T cells, dendritic cells, eosinophils and hyperplas-
tic mast cells. Epidermal infiltrate was composed of
T cells, Langerhans cells and some eosinophils.22
Update on histopathological manifestations of
canine atopic dermatitis
Since the last review, several publications have
addressed the histological features of canine AD skin
lesions using experimental models of AD.23–28 None of
those, however, evaluated histological features of natu-
rally occurring lesions, and the histopathological descrip-
tions were often adjunctive to the primary immunological
questions addressed by the authors. Nevertheless, the
histopathological description of the skin reaction after an
epicutaneous or intradermal delivery of a relevant allergen
or anti-canine IgE antibody injection was generally similar
to that reviewed by the ACVD Task Force in 2001.22 All
the studies focused on the late-phase skin reaction (e.g.
erythema, thickening), which is believed to resemble
lesions seen in dogs with AD. In general, the late-phase
skin reaction was characterized by an inflammatory
pattern consisting of superficial perivascular to interstitial
mononuclear dermatitis with neutrophils and eosinophils.
Degranulation of mast cells and eosinophils was reported
upon allergen challenge.24–28 An irregular epidermal
hyperplasia with lymphocytic and eosinophilic exocytosis
resulting in an occasional formation of eosinophilic
micro-abscesses and infiltration of the lesional skin with
epidermal and dermal dendritic cells were also
reported.24–27
Conclusions
In summary, considerable work has been performed in
the past 10 years to provide a better definition of the clini-
cal appearance and histopathology of canine AD. New
sets of diagnostic criteria have been developed, which
offer an enhanced sensitivity and specificity over older
criteria. This information has led to the development of
two new scoring systems for assessment of lesion sever-
ity, tools necessary for a generation of high-quality medi-
cal evidence. Significant breed-associated differences in
phenotypes have also been demonstrated. However,
these investigations have also demonstrated that food-
induced AD and purely environmental allergen-induced
AD may be clinically indistinguishable in dogs. These limi-
tations imply that a ‘one-size-fits-all’ set of diagnostic or
descriptive criteria for canine AD may not be possible.
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Resume
Contexte – De nombreuses etudes portant sur les signes cliniques et histologiques de la dermatite atopi-
que canine (AD) ont ete publiees depuis ses premieres descriptions, il y a plusieurs dizaines d’annees. Les
donnees de ces etudes contribuent a notre connaissance actuelle de la pathogenie de la maladie et nous
permettent de determiner des criteres de diagnostic utilises par les cliniciens et les chercheurs.
Objectifs – Cette revue sert de mise a jour des criteres cliniques et histologiques de l’AD canine publies
par la Task Force de la dermatite atopique canine du College Americain de Dermatologie Veterinaire en
2001 et resume les decouvertes recentes de ce domaine.
Resultats – Les donnees globales des etudes portant sur les signes cliniques correspondent a celles pub-
liees par la Task Force en 2001. La nouveaute etait le plus grand nombre d’animaux inclus dans ces etudes,
permettant ainsi de determiner un nouvel ensemble de criteres ameliorant la sensibilite et la specificite des
criteres precedents. La me^me etude a permis de mettre en evidence des differences entres les chiens att-
eints d’AD liee a l’alimentation et non-liee a l’alimentation; cependant, les auteurs ont conclu que ces deux
entites ne pouvaient pas e^tre distinguees sur la seule base des signes cliniques. Une autre etude a
demontre des specificites phenotypiques de certaines races. Plusieurs publications ont pris en compte les
criteres histologiques des lesions cutanees de l’AD canine sur des modeles experimentaux d’AD mais au-
cune ne portaient sur des modeles naturels. Neanmoins, la description histopathologique des reactions
cutanees etait generalement semblable a celle publiee par la Task Force en 2001.
Conclusions – Un travail considerable a ete fait recemment pour fournir une meilleure definition clinique et
histopathologique de l’AD canine. De nouveaux criteres de diagnostic ont ete developpes et des
differences phenotypiques associees a des races ont ete demontrees.
Resumen
Introduccion – muchos estudios enfocados en los signos clınicos e histologicos de la dermatitis atıpica
canina (AD) han sido publicados desde las descripciones mas tempranas hace decadas. Los hallazgos de
estudios contribuyeron a nuestro conocimiento actual acerca la patogenia de la enfermedad y permitieron
establecer un criterio diagnostico para ser utilizado por los clınicos y los investigadores.
Objetivos – esta revision sirve como una puesta al dıa de las caracterısticas clınicas e histologicas de la
dermatitis atopica canina publicadas por el colegio americano de dermatologos veterinarios en el grupo de
trabajo de la dermatitis atopica canina en el a~no 2001, y resume los descubrimientos mas recientes en es-
tos campos.
Resultados – los hallazgos de los estudios enfocados en los signos clınicos semejan aquellos publicados
por el grupo de trabajo del a~no 2001. La novedad fue el mayor numero animales incluidos en estos estu-
dios, lo cual permitio establecer un nuevo conjunto de criterios diagnosticos que excedıan la sensibilidad y
la especificidad de los criterios previos. El mismo estudio descubrio algunas diferencias clınicas entre los
perros con dermatitis atopica inducida por comida o por otras causas. Sin embargo los autores concluyen
que estas dos entidades no se pueden distinguir basados solamente en los signos clınicos. Otro estudio
demostro algunos fenotıpicos especıficos de raza. Varias publicaciones estudian las caracterısticas his-
tologicas de las lesiones de dermatitis atıpica en modelos experimentales, pero ninguno estudia las lesi-
ones por causa natural. Sin embargo, las descripciones histopatologicas de la reaccion de la piel fueron
similares a las publicadas por el grupo de trabajo en e a~no 2001.
Conclusiones – se han realizado bastantes trabajos en a~nos recientes para aportar una mejor definicion de
la presentacion clınica y de las caracterısticas histopatologicas de la dermatitis atopica. Se han desarrollado
nuevos conjuntos de criterios diagnosticos, y se han demostrado diferenciacion fenotıpicas dependiendo
de la raza.
© 2015 ESVD and ACVD, Veterinary Dermatology, 26, 79–e24. 83
Clinical appearance and histology of AD
Zusammenfassung
Hintergrund – Viele Studien, die sich auf die klinische und histologische Symptomatik der atopischen Der-
matitis (AD) des Hundes konzentrieren, sind seit der Beschreibung ihrer Charakteristika vor Jahrzehnten
ver€offentlicht worden. Die Ergebnisse dieser Studien haben zu unserem momentanen Wissen €uber die
Pathogenese der Erkrankung beigetragen und erm€oglichten die Erstellung diagnostischer Kriterien, die von
Klinikern und Wissenschaftlern verwendet werden konnten.
Ziele – Diese Review dient als Update der klinischen und histologischen Merkmale der caninen AD, die
von der Task Force des American College f€ur Veterin€ardermatologie 2001 €uber die atopische Dermatitis
des Hundes publiziert worden war und fasst die letzten Entdeckungen auf diesem Gebiet zusammen.
Ergebnisse – Insgesamt entsprachen die Ergebnisse dieser Studien, die sich auf die klinischen Merkmale
bezogen denen von der Task Force 2001 publizierten. Die Neuheit daran war die gr€oßere Anzahl an Tieren,
die in diesen Studien untersucht worden waren, was es erm€oglichte, ein neues Set an diagnostischen
Kriterien zu erstellen, welches die Sensibilit€at und Spezifit€at der vorherigen Kriterien €ubertraf. Dieselbe Stu-
die zeigte einige klinische Unterschiede zwischen Hunden mit Futter-induzierter und Nicht-Futter-induzier-
ter AD; die Autoren wiesen jedoch darauf hin, dass diese zwei Einheiten nicht alleine aufgrund ihrer
klinischen Zeichen unterschieden werden k€onnen. Eine weitere Studie zeigte einige große Rasse-spezifi-
sche Ph€anotypen. Mehrere Publikationen bezogen sich auf die histologischen Merkmale der Hautver€ander-
ungen bei der caninen AD in experimentellen Modellen, aber keine der Studie beschrieb nat€urlich
auftretende L€asionen. Nichtsdestotrotz waren die histopathologischen Beschreibungen der Hautreaktio-
nen generell €ahnlich wie die von der Task Force 2001 publizierten.
Schlussfolgerungen – Eine bedeutende Arbeit wurde in den letzten Jahren geleistet, um eine bessere
Definition der klinischen Erscheinung und der Histopathologie der AD des Hundes zu liefern. Neue Sets an
diagnostischen Kriterien sind entwickelt worden und zus€atzliche rasse-spezifische Unterschiede der
Ph€anotypen wurden gezeigt.
要約
背景 – イヌアトピー性皮膚炎(AD)の臨床的および組織学的な所見に注目した多くの研究が数十年前に初めに解説さ
れて以来、発表されている。これらの研究の所見は疾患の病院に関する我々の知識に貢献し、臨床家や研究者に
よって使用される診断基準の制定を可能にした。
目的– この総説は2001年に American College of Veterinary Dermatology Task Forceによって発表されたイ
ヌADの臨床的および組織学的な特徴のアップデートを扱うとともに、これらの分野での最近の発見を要約する。
結果 – 臨床的な特徴において、全体的な研究の報告は2001年のTask Forceで発表されたものに類似していた。新
しい知見としては、新しい診断基準の制定を認めたこれらの研究に含まれる多数の動物が、以前の基準の感度と特異
度を超えていることである。同じ研究では食物誘発性および非食物誘発性ADのイヌの間のいくつかの臨床的な違いを
明らかにしたが、しかし、筆者らはこれらの2つは臨床所見のみでは区別できないと結論づけた。他の研究はいくつかの
主要な犬種特異性の表現系を立証した。複数の発表ではADの実験モデルにおけるイヌADの皮膚病変の組織学的
な特徴について取り上げているが、いずれの記載も自然発生性のものではない。それにもかかわらず、皮膚反応の病
理組織学的な記載は2001年のTask Forceで発表されたものに概ね類似している。
結論 – イヌのADの臨床症状および病理組織学によりよい説明を示すための多くの仕事が近年に行われていた。新しい
診断基準が開発され、さらなる表現型の犬種関連性の違いが示めされた。
摘要
背景 – 早在几十年前,就有很多聚焦于犬异位性皮炎(AD)的临床及病理学症状的研究发表。这些研究提供给
我们关于该病的病理学知识,并建立供临床医生和研究人员使用的诊断标准。
目的 – 本综述更新了犬AD临床及病理学特性,这是由美国大学的兽医犬异位性皮炎工作组发表于2001年。
本文还总结了目前该领域近期的研究成果。
结果–所有研究的全部结果都集中于临床特征,与工作组于2001年的发表文章相符合。这些新研究包含了大
量动物,建立出一套新的诊断标准,其特异性及敏感性均高于之前的标准。相同研究发现有食物诱导和没有食
物诱导AD的一些临床不同点;然而,作者得出结论,两者不能只靠临床症状区别。作者研究证明一些主要品种
特异性表型。一些实验用AD实验模型来研究犬AD皮肤病变的病理学特征,但是其中没有自然发生的病变。
然而,皮肤反应的组织病理学描述与工作组2001年发表的几乎一致。
总结与临床意义 – 为更好的描述犬AD临床表现及组织病理学特征,近年有相当大的工作需要去做。已经形
成新的诊断标准,品种相关的表型差异也已经被证明。
Bizikova et al.
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